News

Lab-on-Paper can detect low-quality anitmalarial drugs without expensive equipment.

This award had been made in recognition of Porvair’s substantial growth in overseas business, achieving increased year-on-year growth in sales of exported products over the past three years.

A structural study revealed how an antibiotic called borrelidin stops bacterial growth.

Collaboration will see integration of Optibrium’s StarDrop and Certera’s D360 platform.

Flagship Biosciences and ACD collaborate to develop quantitative RNAscope® assays for pharmaceutical clinical trials in the CLIA environment.

Company presents results with APR-246 - a novel candidate drug that restores mutant p53 protein into its wild-type function.

NIH-funded study identifies over-the-counter compounds that may replace damaged cells.

Horizon Discovery Group plc and Thermo Fisher Scientific sign supply and commercialization agreement, which will see Thermo market and distribute Horizon’s X-MAN cell line collection.

Long term data continue to show good safety profile and evidence of sustained improvements in neurological status and limb function.

Aquisition will enable Sartorius to offer increased support to their biopharma clients.